Ticker Details
Pulse Biosciences, Inc. Pulse Biosciences Inc is a development stage medical device company using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling or NPES for biomedical applications.
IPO Date:	May 18, 2016
Sector:	Healthcare
Industry:	Medical Instruments and Equipment
Market Cap:	$1.79B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.49 | 3.73%
Avg Daily Range (30 D):	$0.83 | 3.80%
Avg Daily Range (90 D):	$0.80 | 4.00%

Institutional Daily Volume
Avg Daily Volume:	.13M
Avg Daily Volume (30 D):	.28M
Avg Daily Volume (90 D):	.3M

Trade Size
Avg Trade Size (Sh.):	96
Avg Trade Size (Sh.) (30 D):	63
Avg Trade Size (Sh.) (90 D):	67

Institutional Trades
Total Institutional Trades:	174
Avg Institutional Trade:	$1.37M
Avg Institutional Trade (30 D):	$1.11M
Avg Institutional Trade (90 D):	$1.02M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.36M
Avg Closing Trade (30 D):	$.76M
Avg Closing Trade (90 D):	$.82M
Avg Closing Volume:	90K

News

May 4, 2026 @ 10:27 PM Pulse Biosciences (PLSE) Q1 2025 Earnings Transcri... Source: Motley Fool Transcribing

Apr 1, 2024 @ 7:33 AM Oxford Industries, PVH And 3 Stocks To Watch Headi... Source: Avi Kapoor

Mar 11, 2024 @ 5:41 PM Why Mesoblast Shares Are Trading Higher By 13%? He... Source: Avi Kapoor

Jan 2, 2024 @ 4:47 PM Rivian Automotive Reports Weak Delivery Figures, J... Source: Avi Kapoor

Dec 19, 2023 @ 6:55 PM Tech Stocks Set New All-Time High, Small Caps On F... Source: Piero Cingari

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.1	$-.27	$-.26
Diluted EPS
Revenue	$.75M	$.4M	$.26M
Gross Profit		$.03M	$M
Net Income / Loss	$-74.57M	$-18.58M	$-17.43M
Operating Income / Loss	$-78.05M	$-19.15M	$-18.25M
Cost of Revenue	$.91M	$.37M	$.26M
Net Cash Flow	$-50.96M	$-12.42M	$-14.48M
PE Ratio